SIGA Technologies, Inc.

NasdaqGM:SIGA Voorraadrapport

Marktkapitalisatie: US$516.7m

SIGA Technologies Toekomstige groei

Future criteriumcontroles 0/6

SIGA Technologies zal naar verwachting zijn omzet verhogen met 6.8% per jaar.

Belangrijke informatie

n/a

Groei van de winst

n/a

Groei van de winst per aandeel

Pharmaceuticals winstgroei23.7%
Inkomstengroei6.8%
Toekomstig rendement op eigen vermogenn/a
Dekking van analisten

Low

Laatst bijgewerkt07 Oct 2024

Recente toekomstige groei-updates

Geen updates

Recent updates

SIGA Technologies, Inc. (NASDAQ:SIGA) Not Doing Enough For Some Investors As Its Shares Slump 34%

Sep 14
SIGA Technologies, Inc. (NASDAQ:SIGA) Not Doing Enough For Some Investors As Its Shares Slump 34%

SIGA Technologies: Shares Tanking On Mpox Study Miss, Turbulence May Be Temporary

Aug 15

SIGA Technologies, Inc. (NASDAQ:SIGA) Held Back By Insufficient Growth Even After Shares Climb 31%

Jul 14
SIGA Technologies, Inc. (NASDAQ:SIGA) Held Back By Insufficient Growth Even After Shares Climb 31%

SIGA Technologies: BARDA Contract Renewal Required To Sustain Recent Momentum (Rating Downgrade)

Jun 13

SIGA Technologies, Inc. (NASDAQ:SIGA) Stock Rockets 64% But Many Are Still Ignoring The Company

Mar 31
SIGA Technologies, Inc. (NASDAQ:SIGA) Stock Rockets 64% But Many Are Still Ignoring The Company

Siga Technologies: Preparing For A Contingency If Tomorrow Comes

Mar 25

Shareholders Can Be Confident That SIGA Technologies' (NASDAQ:SIGA) Earnings Are High Quality

Mar 19
Shareholders Can Be Confident That SIGA Technologies' (NASDAQ:SIGA) Earnings Are High Quality

The Price Is Right For SIGA Technologies, Inc. (NASDAQ:SIGA)

Feb 15
The Price Is Right For SIGA Technologies, Inc. (NASDAQ:SIGA)

Do SIGA Technologies' (NASDAQ:SIGA) Earnings Warrant Your Attention?

Jan 13
Do SIGA Technologies' (NASDAQ:SIGA) Earnings Warrant Your Attention?

SIGA Technologies secures new contract awarded to procure up to $10.7M of TPOXX

Sep 29

Siga monkeypox therapy undergoes NIH-led late-stage trial

Sep 09

Scientists behind key COVID study run monkeypox trial for SIGA therapy

Aug 23

SIGA to activate first trial sites for monkeypox therapy in U.K. next week – Bloomberg

Aug 17

Estimating The Fair Value Of SIGA Technologies, Inc. (NASDAQ:SIGA)

Aug 12
Estimating The Fair Value Of SIGA Technologies, Inc. (NASDAQ:SIGA)

SIGA to deliver $26M of monkeypox therapy to U.S. in 2023 after option exercise

Aug 09

SIGA Technologies: Unjustified Selloff, Loading The Boat, Best Monkeypox Play

Aug 01

SIGA Technologies: Buy Monkeypox

Jul 25

Siga Technologies receives approval from UK for tecovirimat

Jul 08

SIGA Technologies: Solid Business With Means To Address Monkeypox Outbreak

May 27

SIGA Technologies: There's An Assured Market For A Smallpox Vaccine

Dec 12

It's Probably Less Likely That SIGA Technologies, Inc.'s (NASDAQ:SIGA) CEO Will See A Huge Pay Rise This Year

Jun 08
It's Probably Less Likely That SIGA Technologies, Inc.'s (NASDAQ:SIGA) CEO Will See A Huge Pay Rise This Year

SIGA Technologies: Biodefense Pharma Unlocks New Value Abroad For TPOXX

Apr 28

Introducing SIGA Technologies (NASDAQ:SIGA), The Stock That Soared 880% In The Last Five Years

Feb 22
Introducing SIGA Technologies (NASDAQ:SIGA), The Stock That Soared 880% In The Last Five Years

We're Not So Sure You Should Rely on SIGA Technologies' (NASDAQ:SIGA) Statutory Earnings

Feb 02
We're Not So Sure You Should Rely on SIGA Technologies' (NASDAQ:SIGA) Statutory Earnings

Winst- en omzetgroeiprognoses

NasdaqGM:SIGA - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/2025187N/AN/AN/A1
12/31/2024160N/AN/AN/A1
6/30/2024173847474N/A
3/31/2024157796464N/A
12/31/2023140689595N/A
9/30/202335-588N/A
6/30/2023982888N/A
3/31/20231093399N/A
12/31/2022111344242N/A
9/30/20222151086666N/A
6/30/2022147727272N/A
3/31/2022139707373N/A
12/31/2021134691111N/A
9/30/202156164141N/A
6/30/202195447171N/A
3/31/2021127646363N/A
12/31/2020125567272N/A
9/30/202091321111N/A
6/30/2020556-20-20N/A
3/31/202019-18-15-15N/A
12/31/201927-7-18-18N/A
9/30/20192450-8-8N/A
6/30/20194874397878N/A
3/31/20194864357777N/A
12/31/20184774226969N/A
9/30/20184773596464N/A
6/30/20187-39-30-30N/A
3/31/20189-39N/A-26N/A
12/31/201712-36N/A-18N/A
9/30/201718-36N/A-35N/A
6/30/201721-36N/A-84N/A
3/31/201719-38N/A-108N/A
12/31/201615-40N/A-117N/A
9/30/201612-49N/A-107N/A
6/30/20169-46N/A-37N/A
3/31/20168-43N/A9N/A
12/31/20158-39N/A11N/A
9/30/20155-38N/A23N/A
6/30/20155-273N/A20N/A
3/31/20154-269N/A-9N/A
12/31/20143-265N/A14N/A
9/30/20143-251N/A4N/A
6/30/20144-16N/A74N/A
3/31/20145-16N/A83N/A
12/31/20136-17N/A58N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Er zijn onvoldoende gegevens om te bepalen of de verwachte winstgroei van SIGA boven de spaarquote ( 2.6% ) ligt.

Winst versus markt: Er zijn onvoldoende gegevens om te bepalen of de winst van SIGA naar verwachting sneller zal groeien dan de markt US

Hoge groeiwinsten: Er zijn onvoldoende gegevens om te bepalen of de winst van SIGA naar verwachting de komende 3 jaar aanzienlijk zal groeien.

Omzet versus markt: De omzet van SIGA ( 6.8% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 8.8% per jaar).

Hoge groei-inkomsten: De omzet van SIGA ( 6.8% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van SIGA naar verwachting over 3 jaar hoog zal zijn


Ontdek groeibedrijven